A new clinical trial has shown promising results for a new treatment for postpartum depression. In this episode, we'll discuss the trial and what it means for women with postpartum depression.
Correction: The intravenous drug Zelresson was erroneously stated as being administerd over 60 minutes. Zelresso is administred over 60 hours (2.5 days).
